Comprehensive Management of Musculoskeletal Disorders in Hemophilia (1973)

Chapter: Cryoprecipitate Utilization in the Home Transfusion Program

Previous Chapter: Therapy of Hemophilia A and B with Plasma and Plasma Fractions
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 67
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 68
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 69
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 70
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 71
Next Chapter: Early Management of Joint and Soft Tissue Bleeding
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.